Integra's Update On FY21 Acell Revenues To Weigh On Stock, Piper Sandler Says
Benzinga
29 Jul 2021
Piper Sandler has raised the price target on Integra LifeSciences Holding Corporation (NASDAQ:IART) to $72 from $70 and reiterated a Neutral rating following the Q2 beat.
The company posted Q2 EPS of $0.79 and sales of $389.9 million, beating the consensus estimate of $0.66 and $376.0 million, respectively.
Despite favorable commentary on the year, management's specific Q3 guidance indicates low single-digit growth to what Integra delivered back in 2019, "which is our primary hang-up on the name," analyst Matt O'Brien tells investors in a research note.
In addition, Integra is reducing its outlook for Acell revenues this year as accessing clinicians is proving more challenging in a pandemic environment.
The company estimates Acell sales of $70 million to $74 million for FY21, from its previous range of $83 million to $88 million.
It raised overall sales forecast by $15 million to a range of $1.54 billion - $1.55 billion from $1.52 billion - $1.53 billion for 2021.
IART also revised its 2021 adjusted EPS guidance to $2.98 - $3.05 (consensus $2.92), from its prior range of $2.86 to $2.93.
For Q3, the company expects revenues of $382 million - $389 million and adjusted EPS of $0.71 to $0.74.
Price Action: IART shares are down 1.03% at $70.47 during the market session on the last check Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.